Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorPASSARO, ANTONIO
dc.contributor.authorAddeo, Alfredo
dc.contributor.authorvon Garnier, Christophe
dc.contributor.authorBlackhall, Fiona
dc.contributor.authorPLANCHARD, DAVID
dc.contributor.authorFELIP, ENRIQUETA
dc.date.accessioned2021-09-23T09:03:19Z
dc.date.available2021-09-23T09:03:19Z
dc.date.issued2020-06-23
dc.identifier.citationPassaro A, Addeo A, Von Garnier C, Blackhall F, Planchard D, Felip E, et al. ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer. ESMO Open. 2020 Jun 23;5:e000820.
dc.identifier.issn2059-7029
dc.identifier.urihttps://hdl.handle.net/11351/6343
dc.descriptionCoronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Lung cancer
dc.description.abstractThe COVID-19 pandemic, characterised by a fast and global spread during the first months of 2020, has prompted the development of a structured set of recommendations for cancer care management, to maintain the highest possible standards. Within this framework, it is crucial to ensure no disruption to essential oncological services and guarantee the optimal care. This is a structured proposal for the management of lung cancer, comprising three levels of priorities, namely: tier 1 (high priority), tier 2 (medium priority) and tier 3 (low priority)—defined according to the criteria of the Cancer Care Ontario, Huntsman Cancer Institute and Magnitude of Clinical Benefit Scale. The manuscript emphasises the impact of the COVID-19 pandemic on lung cancer care and reconsiders all steps from diagnosis, staging and treatment. These recommendations should, therefore, serve as guidance for prioritising the different aspects of cancer care to mitigate the possible negative impact of the COVID-19 pandemic on the management of our patients. As the situation is rapidly evolving, practical actions are required to guarantee the best patients’ treatment while protecting and respecting their rights, safety and well-being. In this environment, cancer practitioners have great responsibilities: provide timely, appropriate, compassionate and justified cancer care, while protecting themselves and their patients from being infected with COVID-19. In case of shortages, resources must be distributed fairly. Consequently, the following recommendations can be applied with significant nuances, depending on the time and location for their use, considering variable constraints imposed to the health systems. An exceptional flexibility is required from cancer caregivers.
dc.language.isoeng
dc.publisherBMJ
dc.relation.ispartofseriesESMO Open;5
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourceScientia
dc.subjectPulmons - Càncer - Tractament
dc.subjectCOVID-19 (Malaltia)
dc.subject.meshLung Neoplasms
dc.subject.mesh/therapy
dc.subject.meshCoronavirus Infections
dc.titleESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1136/esmoopen-2020-000820
dc.subject.decsneoplasias pulmonares
dc.subject.decs/terapia
dc.subject.decsinfecciones por Coronavirus
dc.relation.publishversionhttps://doi.org/10.1136/esmoopen-2020-000820
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Passaro A] Division of Thoracic Oncology, European Institute of Oncology, IRCCS, Milan, Italy. [Addeo A] University Hospital of Geneva Department of Oncology, Geneva, Switzerland. [Von Garnier C] Department of Pulmonary Medicine, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. [Blackhall F] Division of Cancer Sciences, University of Manchester & The Christie NHS Foundation Trust, Manchester, UK. [Planchard D] Department of Medical Oncology, Thoracic Unit, Gustave Roussy, Villejuif, France. [Felip E] Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
dc.identifier.pmid32581069
dc.identifier.wos000557494900003
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record